Director/PDMR Shareholding (2459G)

TIDMHIK

RNS Number : 2459G

Hikma Pharmaceuticals Plc

09 May 2011

Hikma Pharmaceuticals PLC - Share Transactions

LONDON, 9 May 2011: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK) announces that the following Persons Discharging Managerial Responsibility ("PDMR") have exercised awards which vested on 29 April 2011 under the 2005 Long Term Incentive Plan ("LTIP") and which in two cases the holder was required to exercise as part of the vesting process. The exercise price under the LTIP is GBPnil. The persons concerned elected to retain all the shares exercised, subject to, in one case, a disposal to meet a tax liability arising.

In accordance with DTR 3.1.2R and s.793 of the Companies Act 2006, Hikma announces that the following transactions took place in London over the Company's Ordinary Shares of 10p each as detailed below.

 
             Type of                                          Shares         Outstanding 
 PDMR        Transaction    Exercised      Date    Price      Disposed        Holding 
             Exercise of 
 Mazen        LTIP 2007     104,000        9 May                             799,225 
  Darwazah    & 2008         (0.06% ISC)    2011   GBP7.92    Nil            (0.41%) 
            -------------  -------------  ------  ---------  -------------  ------------ 
                                                                             379,568 
 Bassam      Exercise of    54,000         9 May                             (0.19% 
  Kanaan      LTIP 2008      (0.03% ISC)    2011   GBP7.92    Nil            ISC) 
            -------------  -------------  ------  ---------  -------------  ------------ 
                                                                             12,200 
 Michael     Exercise of    27,000         9 May              14,800         (0.01% 
  Raya        LTIP 2008      (0.01% ISC)    2011   GBP7.92     (0.01% ISC)   ISC) 
            -------------  -------------  ------  ---------  -------------  ------------ 
 Majda       Exercise of    54,000         9 May                             108,445 
  Labadi      LTIP 2008      (0.03% ISC)    2011   GBP7.92    Nil            (0.06%) 
            -------------  -------------  ------  ---------  -------------  ------------

- ENDS -

Enquiries:

Hikma Pharmaceuticals PLC

Henry Knowles +44 20 7399 2760

Company Secretary

Susan Ringdal +44 20 7399 2760

Investor Relations Director

About Hikma

Hikma Pharmaceuticals PLC is a fast growing multinational group focused on developing, manufacturing and marketing a broad range of both branded and non-branded generic and in-licensed pharmaceutical products. Hikma's operations are conducted through three businesses: "Branded", "Injectables" and "Generics". Hikma's operations are based principally in the Middle East and North Africa ("MENA") region, where it is a market leader and sells across 17 countries, the United States and Europe. In 2010, the Group achieved revenues of $731 million (2009 $637 million) and profit attributable to shareholders was $99 million (2009 $78 million). For news and other information, please visit www.hikma.com.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSBLGDUUSGBGBC

Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024